Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587517 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
A Phase 2 study of Trauma and Grief, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
- 3
- Study locations
NCT05587517 is a Phase 2 study of Trauma and Grief that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 172 participants, below the 304-participant average among 56 other Trauma trials with a reported enrollment target (43% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05587517, a Phase 2 study of Trauma and Grief, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
- 3
- Study locations
Study Summary
Hypotheses 1a and 1b: Compared to Supportive Conversation arm, the EMPOWER intervention will significantly decrease surrogate decision makers' symptoms of grief and Post Traumatic Stress Disorder (PTSD) (primary outcomes); and H1b. experiential avoidance, depression, regrets, and increases in patients' value-concordant care (secondary outcomes) at T1-T4. Hypothesis 2. Qualitative data will provide insights not captured by quantitative data. Hypothesis 3. Reductions in experiential avoidance will mediate reductions in grief and Post Traumatic Stress Disorder (PTSD) symptoms, highlighting it as important to target in future implementation.
Conditions Studied
Interventions
- BEHAVIORAL EMPOWER
- OTHER Supportive Conversation
Study Locations (3)
New York
- Memorial Sloan Kettering Cancer Center - New York
- NewYork-Presbyterian Weill Cornell Medicine - New York
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2027-12-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587517
The ClinicalTrials.gov registry entry for NCT05587517 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 56 other Trauma trials with a reported enrollment target (43% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which EMPOWER is the first listed.
NCT05587517 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Florida.
Frequently Asked Questions
What is clinical trial NCT05587517 about?
NCT05587517 is a clinical study titled "A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients". Hypotheses 1a and 1b: Compared to Supportive Conversation arm, the EMPOWER intervention will significantly decrease surrogate decision makers' symptoms of grief and Post Traumatic Stress Disorder (PTSD) (primary outcomes); and H1b. experiential avoidance, depression, regrets, and increases in patien...
What is the current status of trial NCT05587517?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2022-10-11. Estimated completion is 2027-12-11.
What conditions does trial NCT05587517 study?
This clinical trial studies the following conditions: Trauma, Grief, Critical Care, Psychotherapy.
What interventions are being tested in trial NCT05587517?
The interventions under investigation include: EMPOWER (BEHAVIORAL), Supportive Conversation (OTHER).
Who is sponsoring clinical trial NCT05587517?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587517 being conducted?
This trial has 3 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
RECRUITING · Phase 2
-
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
ACTIVE NOT RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.